Work

Abstract PS5-04-09: Pathological complete response rates, treatment patterns, and survival outcomes in high risk, neoadjuvant-treated HER2-positive early breast cancer: a Canadian chart review

Year: 2026

Type: conference-abstract

Source: Clinical Cancer Research

DOI: 10.1158/1557-3265.sabcs25-ps5-04-09

Authors: W. Y. Cheung, J.-W. Henning, S. Shokar, M. T. Warkentin, Z. Senhaji Mouhri, M. Badin, A. Nam

Institutions: University of Calgary, AstraZeneca (Canada)

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7129540782

Cites:

Cited by:

Related to: